Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
Clinical Trials and Cohort Studies Grants 2021 are now open for applications in Sapphire.
This funding scheme is open to research proposals for clinical trials and/or cohort studies of any size – that is, they may be large or small clinical trials or cohort studies.
The intended outcomes of the Clinical Trials and Cohort Studies Grants scheme are improvements in health and well-being, health care practice or policy, as a result of:
- High-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates).
- High-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.
- High quality retrospective cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.
If you will be applying for a Clinical Trial Cohort Studies Grant and have not yet registered for a Sapphire account you will need to register here.
Where to go for assistance
Resources are available to assist you in navigating Sapphire, such as Help (a list of frequently asked questions), how-to videos and access to the Sapphire Help Desk. The Sapphire Helpdesk will be available by email and telephone to assist you with any questions and issues.
NHMRC will update Sapphire’s NHMRC web page with latest news and other relevant information. We encourage you to check back regularly to keep yourself informed.
Clinical Trials and Cohort Studies Grants may be funded by or in conjunction with other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations.
For the Clinical Trials and Cohort Studies Grants 2021 opportunity, the funding partner/s include:
• Cancer Australia & Funding Partners.
Peer Review Information
Applications to the Clinical Trials and Cohort Studies Grants 2021 opportunity will be assessed in accordance with the assessment criteria set out in the Grant Guidelines that are now available on GrantConnect. The category descriptors are also provided within the Grant Guidelines.
For details regarding the Clinical Trials and Cohort Studies 2021 peer review process, please refer to the 2021 Peer Review Guidelines available from the download section below.